You are here

Article info

Article menu

Download PDFPDF

XML
Review
Neuropilin-1: a checkpoint target with unique implications for cancer immunology and immunotherapy

Authors

  • Christopher A Chuckran Department of Immunology, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA Tumor Microenvironment Center and the Cancer Immunology and Immunotherapy Program, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA Graduate Program of Microbiology and Immunology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA PubMed articlesGoogle scholar articles
  • Chang Liu Department of Immunology, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA Tumor Microenvironment Center and the Cancer Immunology and Immunotherapy Program, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA Cancer Immunology and Immunotherapy Program, UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, USA PubMed articlesGoogle scholar articles
  • Tullia C Bruno Department of Immunology, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA Tumor Microenvironment Center and the Cancer Immunology and Immunotherapy Program, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA Cancer Immunology and Immunotherapy Program, UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, USA PubMed articlesGoogle scholar articles
  • Creg J Workman Department of Immunology, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA Tumor Microenvironment Center and the Cancer Immunology and Immunotherapy Program, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA PubMed articlesGoogle scholar articles
  • Dario AA Vignali Department of Immunology, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA Cancer Immunology and Immunotherapy Program, UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, USA PubMed articlesGoogle scholar articles

Citation

Chuckran CA, Liu C, Bruno TC, et al
Neuropilin-1: a checkpoint target with unique implications for cancer immunology and immunotherapy
Journal for ImmunoTherapy of Cancer 2020;8:e000967. doi: 10.1136/jitc-2020-000967
Online issue publication 
July 15, 2020

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.